Ignite Creation Date:
2025-12-24 @ 3:32 PM
Ignite Modification Date:
2026-01-05 @ 9:46 AM
Study NCT ID:
NCT05810792
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-22
First Post:
2023-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer
Sponsor:
Sahlgrenska University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-07
First Submit QC Date:
None
Study First Post Date:
2023-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-20
Last Update Post Date:
2023-11-22
Last Update Post Date Type:
ACTUAL